Solifenacin Succinate NDC 72205-020

NDC codes

FDA NDC Directory

Product NDC (as listed)72205-020Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72205-0020Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
72205-020-30	72205002030	30 TABLET in 1 BOTTLE (72205-020-30)Marketed from May 20, 2019
72205-020-90	72205002090	90 TABLET in 1 BOTTLE (72205-020-90)Marketed from May 20, 2019
72205-020-99	72205002099	1000 TABLET in 1 BOTTLE (72205-020-99)Marketed from May 20, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Solifenacin Succinate
Generic name (nonproprietary): solifenacin succinate
Active ingredients: Solifenacin succinate — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Novadoz Pharmaceuticals LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210688
Marketing start: May 20, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 72205-020_eaccb7fc-2098-43d1-a64e-759b8d4c35c2SPL ID eaccb7fc-2098-43d1-a64e-759b8d4c35c2SPL set ID 98b99a4c-201d-46ee-b78c-7634a64d3a8dRxCUI 477367, 477372UNII KKA5DLD701UPC 0372205021907, 0372205020306, 0372205021303, 0372205020900
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472205002030 followed by a unit qualifier and the quantity

Package 72205-0020-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 1, 2020.

Indications (excerpt from the label)

Solifenacin succinate tablet is indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Solifenacin succinate tablet is a muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210688

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210688
Product	Strength	Form · route	Labeler	Product NDC
Solifenacin Succinate	Solifenacin succinate 10 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-021